Showing 361-370 of 985 results for "".
Exploring Hydrochlorothiazide Use and Skin Cancer Risk
https://practicaldermatology.com/topics/skin-cancer-photoprotection/exploring-hydrochlorothiazide-use-and-skin-cancer-risk/20446/A commonly used antihypertensive appears to be linked to an increased risk of SCC. What should dermatologists do?Phototherapy's Role in the Shifting Spectrum of Psoriasis Care
https://practicaldermatology.com/topics/psoriasis/phototherapys-role-in-the-shifting-spectrum-of-psoriasis-care/21087/Phototherapy has been pushed to the fringe of psoriasis treatment, but new research and innovation in delivery suggest it deserves its place in the changing treatment paradigm.Critical Factors to Advancing Melanoma Diagnosis and Treatment
https://practicaldermatology.com/topics/skin-cancer-photoprotection/critical-factors-to-advancing-melanoma-diagnosis-and-treatment/22970/Dermatologists need to stay abreast of technologies for evaluation of lesions and ensure that medical oncologists within their referral network recognize the importance of clinical trials.Better Brow Lifts
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/better-brow-lifts/18302/An effective neuromodulator brow lift depends on identifying two key points that will help determine the ideal injection location, says Joel L. Cohen, MD, a dermatologist in Greenwood Village, CO. The key is to inject the orbicularis oculi only and to avoid the frontalis entirely. Dr. Cohen is co-edThe Excimer Laser for Psoriasis: A Review of Safety and Efficacy
https://practicaldermatology.com/topics/practice-management/the-excimer-laser-for-psoriasis-a-review-of-safety-and-efficacy/21883/Specialists describe the evolving role of the excimer laser in treating psoriasis.Pearls for Management of Steroid-Responsive Dermatoses
https://practicaldermatology.com/topics/general-topics/pearls-for-management-of-steroid-responsive-dermatoses/21958/From side effects to therapeutic combinations to consider, here is an update on the latest approaches to management of steroid-responsive dermatoses.Journal Club: Dupilumab and Atopic March
https://reachmd.com/programs/Practical-Dermatology-Atopic-Dermatitis-Journal-Club/journal-club-dupilumab-and-atopic-march/32405/Practical Dermatology Associate Medical Editor Elizabeth (Lisa) Swanson, MD, FAAD, and Editorial Board member Peter Lio, MD, discuss recent research indicating a reduced risk of atopic march in pediatric atopic dermatitis patients on dupilumab.Lin TL, Fan YH, Fan KS, Juan CK, Chen YJ, Wu CY. ReducedJournal Club: Dupilumab and Risk of Malignancy
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/journal-club-dupilumab-and-risk-of-malignancy/32398/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, speaks with Matthew Zirwas, MD, about the Journal of Allergy and Clinical Immunology: In Practice article "Risk of malignancy associated with use of dupilumab versus other treatments in atopic dermatitis patients: A national databaseWomen in Dermatology With Brooke Jackson, MD
https://practicaldermatology.com/topics/practice-management/women-in-dermatology-with-brooke-jackson-md/23218/Sclerodermoid Reaction Due to Injection of Fish Oil
https://practicaldermatology.com/youngmd-connect/resident-resource-center/sclerodermoid-reaction-due-to-injection-of-fish-oil/20574/